FMP
Aethlon Medical, Inc.
AEMD
NASDAQ
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.
0.57 USD
0.0159 (2.79%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Mr. James B. Frakes M.B.A.
sector
Healthcare
industry
Medical - Devices
exchange
NASDAQ
Description
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.
CIK
0000882291
ISIN
US00808Y4061
CUSIP
00808Y307
Address
11555 Sorrento Valley Road
Phone
619 941 0360
Country
US
Employee
14
IPO Date
Mar 4, 1999
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
AEMD Financial Summary
CIK
0000882291
Exchange
NASDAQ
Industry
Medical - Devices
Sector
Healthcare
CUSIP
00808Y307
ISIN
US00808Y4061
Country
US
Price
0.57
Beta
1.75
Volume Avg.
2.43M
Market Cap
7.95M
Shares
-
52-Week
0.24-2.35
DCF
1.79
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.2
P/B
-
Website
https://www.aethlonmedical.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest AEMD News
It looks like there's no news available.
